Organometallic anticancer compounds G Gasser, I Ott, N Metzler-Nolte Journal of medicinal chemistry 54 (1), 3-25, 2010 | 1757 | 2010 |
Combination of Ru (II) complexes and light: new frontiers in cancer therapy C Mari, V Pierroz, S Ferrari, G Gasser Chemical Science 6 (5), 2660-2686, 2015 | 583 | 2015 |
Critical Overview of the Use of Ru (II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy F Heinemann, J Karges, G Gasser Accounts of chemical research 50 (11), 2727-2736, 2017 | 539 | 2017 |
The potential of organometallic complexes in medicinal chemistry G Gasser, N Metzler-Nolte Current opinion in chemical biology 16 (1-2), 84-91, 2012 | 524 | 2012 |
The medicinal chemistry of ferrocene and its derivatives M Patra, G Gasser Nature Reviews Chemistry 1 (9), 0066, 2017 | 488 | 2017 |
Highly Charged Ruthenium (II) Polypyridyl Complexes as Lysosome‐Localized Photosensitizers for Two‐Photon Photodynamic Therapy H Huang, B Yu, P Zhang, J Huang, Y Chen, G Gasser, L Ji, H Chao Angewandte Chemie International Edition 54 (47), 14049-14052, 2015 | 427 | 2015 |
Targeted photoredox catalysis in cancer cells H Huang, S Banerjee, K Qiu, P Zhang, O Blacque, T Malcomson, ... Nature chemistry 11 (11), 1041-1048, 2019 | 324 | 2019 |
Molecular and cellular characterization of the biological effects of ruthenium (II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid V Pierroz, T Joshi, A Leonidova, C Mari, J Schur, I Ott, L Spiccia, S Ferrari, ... Journal of the American Chemical Society 134 (50), 20376-20387, 2012 | 313 | 2012 |
Classification of Metal-Based Drugs according to Their Mechanisms of Action E Boros, PJ Dyson, G Gasser Chem 6 (1), 41-60, 2020 | 292 | 2020 |
Underestimated Potential of Organometallic Rhenium Complexes as Anticancer Agents A Leonidova, G Gasser ACS chemical biology 9 (10), 2180-2193, 2014 | 286 | 2014 |
Small organometallic compounds as antibacterial agents M Patra, G Gasser, N Metzler-Nolte Dalton Transactions 41 (21), 6350-6358, 2012 | 276 | 2012 |
Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology? SA McFarland, A Mandel, R Dumoulin-White, G Gasser Current Opinion in Chemical Biology 56, 23-27, 2020 | 272 | 2020 |
Visible‐light‐induced annihilation of tumor cells with platinum–porphyrin conjugates A Naik, R Rubbiani, G Gasser, B Spingler Angewandte Chemie 126 (27), 7058-7061, 2014 | 236 | 2014 |
Organometallic compounds: an opportunity for chemical biology? M Patra, G Gasser ChemBioChem 13 (9), 1232-1252, 2012 | 223 | 2012 |
Rationally designed ruthenium complexes for 1-and 2-photon photodynamic therapy J Karges, S Kuang, F Maschietto, O Blacque, I Ciofini, H Chao, G Gasser Nature communications 11 (1), 3262, 2020 | 208 | 2020 |
Monomeric and dimeric coordinatively saturated and substitutionally inert Ru (II) polypyridyl complexes as anticancer drug candidates A Notaro, G Gasser Chemical Society Reviews 46 (23), 7317-7337, 2017 | 203 | 2017 |
DNA Intercalating RuII Polypyridyl Complexes as Effective Photosensitizers in Photodynamic Therapy C Mari, V Pierroz, R Rubbiani, M Patra, J Hess, B Spingler, L Oehninger, ... Chemistry-A European Journal 20 (44), 14421-14436, 2014 | 197 | 2014 |
Synthesis, Characterization, and Biological Evaluation of New Ru (II) Polypyridyl Photosensitizers for Photodynamic Therapy A Frei, R Rubbiani, S Tubafard, O Blacque, P Anstaett, A Felgenträger, ... Journal of medicinal chemistry 57 (17), 7280-7292, 2014 | 178 | 2014 |
Towards cancer cell-specific phototoxic organometallic rhenium (I) complexes A Leonidova, V Pierroz, R Rubbiani, J Heier, S Ferrari, G Gasser Dalton Transactions 43 (11), 4287-4294, 2014 | 178 | 2014 |
A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers J Karges, T Yempala, M Tharaud, D Gibson, G Gasser Angewandte Chemie International Edition 59 (18), 7069-7075, 2020 | 175 | 2020 |